Aristotle Atlantic Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-24,099
| Closed | -$3.77M | – | 105 |
|
|
2020
Q4 | $3.77M | Buy |
24,099
+2,401
| +11% | +$375K | 0.29% | 56 |
|
|
2020
Q3 | $2.48M | Buy |
21,698
+1,563
| +8% | +$179K | 0.22% | 60 |
|
|
2020
Q2 | $2.26M | Buy |
20,135
+5,397
| +37% | +$606K | 0.22% | 60 |
|
|
2020
Q1 | $1.32M | Buy |
14,738
+5,324
| +57% | +$478K | 0.2% | 62 |
|
|
2019
Q4 | $1.02M | Buy |
9,414
+1,262
| +15% | +$136K | 0.13% | 72 |
|
|
2019
Q3 | $798K | Buy |
8,152
+3,976
| +95% | +$389K | 0.23% | 72 |
|
|
2019
Q2 | $547K | Buy |
+4,176
| New | +$547K | 0.16% | 76 |
|